Wednesday, February 5th, 2025

BioNTech to produce 2 billion doses of COVID-19 vaccine in 2021 amid surge in global demand


02 February 2021  

Time taken to read : 2 Minute


  • A
  • A
  • A

MAINZ:  German biotechnology company BioNTech is planning to produce two billion doses of COVID-19 vaccine in 2021 because of the increase in global demand, the company has said in a statement.

“In order to respond to an increased global demand, we plan to manufacture two billion doses of our COVID-19 vaccine in 2021 by expanding the previously expected output of 1.3 billion doses by more than 50 per cent,” the company said in a press release.

“We are on track to scale-up our manufacturing capacities,” the statement said.  The company, which developed the vaccine with US-based pharma Pfizer, said the modification of production processes at Pfizer’s facility in Puurs, Belgium, had been successfully completed.

“The modification of production processes at Pfizer’s facility in Puurs, Belgium, has been successfully completed. Now, we are back to the original schedule of vaccine dose deliveries to the European Union,” it said.

According to Johns Hopkins University, 103,409,402 Covid-19 cases have been recorded globally with over 2,237,973 deaths. (ANI)

Publish Date : 02 February 2021 15:35 PM

Visiting Duchess of Edinburgh praises Nepal’s eye care achievements

KATHMANDU: Sophie, the Duchess of Edinburgh, a member of the

Gagan Thapa: Shekhar Dai and I are together until the 15th General Convention

KATHMANDU: Nepali Congress General Secretary Gagan Kumar Thapa has stated

Chitwan District Court sends Rabi Lamichhane to judicial custody

KATHMANDU: The Chitwan District Court has ordered Rastriya Swatantra Party

PM Oli pledges to address issues of tea export

KATHMANDU: Prime Minister KP Sharma Oli has pledged to make

Triangular Series: Nepal loses match against Netherlands by 10 wickets

KATHMANDU: Nepal lost today’s match in the 2025 Nepal Women’s